Exact Mass: 387.168179
Exact Mass Matches: 387.168179
Found 150 metabolites which its exact mass value is equals to given mass value 387.168179,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Same as: D01468
1-[(6-Chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol
C21H26ClN3O2 (387.17134460000005)
DV 7751a
C20H22FN3O4 (387.15942640000003)
(2S,3S)-Nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
Cystodytin F
An alkaloid that is an enamide obtained by the formal condensation of 3-methylbut-2-enoic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells.
Cystodytin G
An alkaloid that is an enamide obtained by the formal condensation of tiglic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells
Ala Asn Pro Ser
Ala Asn Ser Pro
Ala Pro Asn Ser
Ala Pro Ser Asn
Ala Ser Asn Pro
Ala Ser Pro Asn
Gly Asn Pro Thr
Gly Asn Thr Pro
Gly Pro Asn Thr
Gly Pro Gln Ser
Gly Pro Ser Gln
Gly Pro Thr Asn
Gly Gln Pro Ser
Gly Gln Ser Pro
Gly Ser Pro Gln
Gly Ser Gln Pro
Gly Thr Asn Pro
Gly Thr Pro Asn
Asn Ala Pro Ser
Asn Ala Ser Pro
Asn Gly Pro Thr
Asn Gly Thr Pro
Asn Pro Ala Ser
Asn Pro Gly Thr
Asn Pro Ser Ala
Asn Pro Thr Gly
Asn Ser Ala Pro
Asn Ser Pro Ala
Asn Thr Gly Pro
Asn Thr Pro Gly
Pro Ala Asn Ser
Pro Ala Ser Asn
Pro Gly Asn Thr
Pro Gly Gln Ser
Pro Gly Ser Gln
Pro Gly Thr Asn
Pro Asn Ala Ser
Pro Asn Gly Thr
Pro Asn Ser Ala
Pro Asn Thr Gly
Pro Gln Gly Ser
Pro Gln Ser Gly
Pro Ser Ala Asn
Pro Ser Gly Gln
Pro Ser Asn Ala
Pro Ser Gln Gly
Pro Thr Gly Asn
Pro Thr Asn Gly
Gln Gly Pro Ser
Gln Gly Ser Pro
Gln Pro Gly Ser
Gln Pro Ser Gly
Gln Ser Gly Pro
Gln Ser Pro Gly
Ser Ala Asn Pro
Ser Ala Pro Asn
Ser Gly Pro Gln
Ser Gly Gln Pro
Ser Asn Ala Pro
Ser Asn Pro Ala
Ser Pro Ala Asn
Ser Pro Gly Gln
Ser Pro Asn Ala
Ser Pro Gln Gly
Ser Gln Gly Pro
Ser Gln Pro Gly
Thr Gly Asn Pro
Thr Gly Pro Asn
Thr Asn Gly Pro
Thr Asn Pro Gly
Thr Pro Gly Asn
Thr Pro Asn Gly
endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride
C22H26ClNO3 (387.16011160000005)
N-(tert-butoxycarbonyl)-3,4-dihydroxy-L-Pheny lalanine benzyl ester
1-[(TERT-BUTYL)OXYCARBONYL]-3-[4-(TRIFLUOROMETHYL)BENZYL]PIPERIDINE-3-CARBOXYLIC ACID
C19H24F3NO4 (387.16573400000004)
N-[(2S,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide
C21H26ClN3O2 (387.17134460000005)
(4S)-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole
C25H26NOP (387.17519160000006)
ETHYL 4-(2-(4-CYANOPHENYLAMINO)PYRIMIDIN-4-YLAMINO)-3,5-DIMETHYLBENZOATE
9-(2-Carboxyphenyl)-3,6-bis(dimethylamino)xanthylium
7-[oxo-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-3-prop-2-enyl-1H-quinazoline-2,4-dione
Cyclopentanecarboxylic acid [1-(benzothiazole-2-carbonyl)-4-guanidino-butyl]-amide
N-(3-imidazol-1-ylpropyl)-8-(4-methoxyphenyl)-1,6-naphthyridine-2-carboxamide
(Z)-5-[(1S,2R)-2-[2-[[(1S)-1-carboxy-2-phenylethyl]amino]-2-oxoethyl]-5-oxocyclopentyl]pent-3-enoic acid
(2S,3S)-Nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
N-(5-methyl-3-isoxazolyl)-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide
2-(2-hydroxyphenyl)-3-[(E)-1-(4-methoxyphenyl)ethylideneamino]-1,2-dihydroquinazolin-4-one
2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide
3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide
C21H23F2N3O2 (387.17582419999997)
3-Furanyl-[4-(5-methyl-2-phenyl-7-pyrazolo[1,5-a]pyrimidinyl)-1-piperazinyl]methanone
1-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone
2-(1,3-Benzoxazol-2-ylamino)-7,7-dimethyl-4-(2-pyridinyl)-1,4,6,8-tetrahydroquinazolin-5-one
N-[4-[[[6-(3,5-dimethyl-4-isoxazolyl)-4-quinazolinyl]amino]methyl]phenyl]acetamide
1-(4-(5-(Furan-2-yl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanone
N-[2-[(2E)-2-[(3-hydroxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]-2,2-diphenylacetamide
1-[(1S,5R)-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-2-pyridin-4-ylethanone
N-[(E)-(5-fluoro-2-hydroxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)heptanediamide
C20H22FN3O4 (387.15942640000003)
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
MHY1485
C17H21N7O4 (387.16549460000005)
MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1]. MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1].
(1r,10s)-3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione
5,17-dihydroxy-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-11-ium-11-olate
(5s)-5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol
5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol
16-oxohasubanonine
{"Ingredient_id": "HBIN001944","Ingredient_name": "16-oxohasubanonine","Alias": "NA","Ingredient_formula": "C21H25NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16330","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}